GlassScriptPhysician profile
Stacey D Jackson
NPI 1134645674
$306.81
in general payments reported to CMS, 2019-2025
15 companies · $31.55 in 2025
The $31.55 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $232 · 2022: $43.59 · 2025: $31.55.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $31.55.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $31.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $48.33 | 2021 | |
| Genzyme Corporation | $43.59 | 2022 | |
| Abbott Laboratories | $39.80 | 2021 | |
| Optinose US, INC. | $19.13 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $18.04 | 2021 | |
| Dexcom, INC. | $17.13 | 2025 | Dexcom G6 Transmitter |
| Novo Nordisk INC | $16.62 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $15.04 | 2021 | |
| Lilly USA, LLC | $14.45 | 2021 | |
| Exact Sciences Corporation | $14.42 | 2025 | Cologuard Collection Kit |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $12.87 | 2021 | |
| Astellas Pharma US INC | $12.63 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $12.56 | 2021 | |
| Antares Pharma, INC. | $11.16 | 2021 | |
| Currax Pharmaceuticals LLC | $11.04 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stacey Jackson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.